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I have read with great interest the article by Emre et 
al.1 Their work showed that sodium nitroprusside could be 
elegantly used to reduce intestinal ischemia reperfusion. This 
is underscored by a decrease in inflammation as compared 
to using a placebo. I would like to further discuss this 
article by introducing a major route through which sodium 
nitroprusside could suppress inflammation.
The recent focus on ischemia-reperfusion injury has 
been on the interaction between neutrophils and endothelial 
cells. Transendothelial migration of neutrophils, with 
release of reactive oxygen species and cytokines, causes 
further damage to the injured tissue.2,3 However, key 
components in the pathogenesis of reperfusion syndrome 
include the up-regulation of surface adhesion molecules on 
the vascular endothelium and their subsequent interaction 
with activated neutrophils.4 The most important adhesion 
protein identified on neutrophils is the integrin lymphocyte 
function-associated antigen-1 (LFA-1; CD11a/CD18). 
This is the ligand for intercellular adhesion molecule-1 
(ICAM-1), which is expressed on the endothelium. The 
LFA-1/ICAM-1 interaction is crucial for neutrofils to ingress 
into inflammatory sites.5,6 Sodium nitroprusside down-
regulates ICAM-1 and LFA-1 expression, and interferes with 
the ICAM-1–LFA-1 interaction by binding to LFA-1.7,8 This 
important mechanism should be borne in mind as the major 
mechanism for sodium nitroprusside-induced inhibition of 
neutrophil activity.
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